文献速递外周动脉疾病

间歇性跛行与严重肢体缺血血运重建患者的截肢率、死亡率及术前合并症:一项基于人群的研究

Amputation Rates, Mortality, and Pre-operative Comorbidities in Patients Revascularised for Intermittent Claudication or Critical Limb Ischaemia: A Population Based Study.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2017-08-07

基于瑞典国家血管外科质量登记库(Swedvasc)的观察性队列研究,纳入2008年5月至2013年5月期间因间歇性跛行(IC)或严重肢体缺血(CLI)接受血运重建的50岁以上下肢外周动脉疾病(PAD)患者共16,889例(IC 6,272例,CLI 10,617例)。主要发现:IC患者截肢年发生率为0.4%;CLI患者血运重建后6个月内截肢率为12.0%,之后降至约每年2%;3年死亡或截肢累积发生率IC为12.9%,CLI为48.8%;CLI患者糖尿病、缺血性卒中、心力衰竭、心房颤动患病率约为IC患者的两倍,肾衰竭近三倍。

要点

  • CLI患者血运重建后6个月内截肢风险最高(12.0%),之后降至约每年2%。
  • IC患者肢体丢失风险低(年截肢率0.4%),但死亡或截肢3年累积发生率仍达12.9%。
  • CLI患者合并症负担显著高于IC,糖尿病、卒中、心衰、房颤约翻倍,肾衰竭近三倍。

核心结论

  • CLI患者血运重建后最初6个月截肢风险特别高,之后截肢风险显著下降。
  • IC患者肢体丢失风险低,但IC与CLI患者的死亡率均较高。
  • 血运重建的CLI患者与IC患者具有不同的合并症特征。

研究设计与样本

  • 观察性队列研究,数据来自瑞典国家血管外科质量登记库(Swedvasc)联合强制性国家医疗登记和患者病历。
  • 纳入2008年5月至2013年5月在瑞典因IC或CLI接受血运重建、年龄50岁及以上的患者。
  • 共纳入16,889例PAD患者,其中IC 6,272例,CLI 10,617例。

主要发现

  • IC患者截肢年发生率为0.4%(范围0.3%-0.5%)。
  • CLI患者血运重建后6个月内截肢率为12.0%(95% CI 11.3-12.6),之后降至约每年2%。
  • 血运重建后3年死亡或截肢累积发生率IC为12.9%(95% CI 12.0-13.9),CLI为48.8%(95% CI 47.7-49.8)。
  • 年龄标准化后,CLI患者糖尿病、缺血性卒中、心力衰竭和心房颤动患病率约为IC患者的两倍,肾衰竭近三倍。

临床怎么用

  • 对CLI患者血运重建后应加强术后6个月内的监测和保肢管理。
  • 对IC和CLI患者均应重视长期死亡风险评估与管理。
  • 对CLI患者需全面评估并管理糖尿病、卒中、心衰、房颤和肾衰竭等合并症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aims of this population based study were to describe mid- to long-term amputation risk, cumulative incidence of death or amputation, and differences in pre-operative comorbidities in patients revascularised for lower limb peripheral artery disease (PAD). METHODS: This was an observational cohort study. Data from the Swedish National Quality Registry for Vascular Surgery (Swedvasc) were combined with mandatory national health care registries and patient medical records. All patients who underwent revascularisation in Sweden between May 2008 and May 2013 for intermittent claudication (IC) or critical limb ischaemia (CLI), aged 50 years and older, were identified through the Swedvasc database. The mandatory national health care registries and medical records provided data on comorbidities, mortality, and major amputations. RESULTS: A total of 16,889 patients with PAD (IC, n = 6272; CLI, n = 10,617) were studied. The incidence of amputations in IC patients was 0.4% (range 0.3%-0.5%) per year. Among CLI patients, the amputation rate during the first 6 months following revascularisation was 12.0% (95% CI 11.3-12.6). Thereafter, the incidence declined to approximately 2% per year. The cumulative combined incidence of death or amputation 3 years after revascularisation was 12.9% (95% CI 12.0-13.9) in IC patients and 48.8% (95% CI 47.7-49.8) in CLI patients. Among CLI patients, compared with IC patients, the prevalence of diabetes, ischaemic stroke, heart failure, and atrial fibrillation was approximately doubled and renal failure was nearly tripled, even after age standardisation. CONCLUSION: The risk of amputation is particularly high during the first 6 months following revascularisation for CLI. IC patients have a benign course in terms of limb loss. Mortality in both IC and CLI patients is substantial. Revascularised CLI patients have different comorbidities from IC patients.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Baubeta Fridh E, Andersson M, Thuresson M, et al. Amputation Rates, Mortality, and Pre-operative Comorbidities in Patients Revascularised for Intermittent Claudication or Critical Limb Ischaemia: A Population Based Study. Eur J Vasc Endovasc Surg. 2017. PMID: 28797662. doi:10.1016/j.ejvs.2017.07.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。